CAM
INO icon

ClariVest Asset Management’s Inovio Pharmaceuticals INO Stock Holding History

ClariVest Asset Management’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-3,896
Closed -$542K – 783
2020
Q3 		$542K Sell
3,896
-1,851
-32% -$386K 0.02% 349
2020
Q2 		$1.86M Buy
+5,747
New +$923K 0.05% 240

Other funds holding INO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ClariVest Asset Management's INO Position: Q4 2020 in Review

ClariVest Asset Management sold out of Inovio Pharmaceuticals (INO) in Q4 2020, closing a stake of 3,896 shares — an estimated $542K sold.

ClariVest Asset Management first reported a position in INO in Q2 2020 and held it in 2 quarters. The position peaked at $1.86M in Q2 2020. 227 funds tracked by Wall St. Rank hold INO as of Q4 2020.

  • ClariVest Asset Management reported no remaining Inovio Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • ClariVest Asset Management sold 3,896 Inovio Pharmaceuticals shares in Q4 2020, an estimated $542K.
  • ClariVest Asset Management first reported a position in Inovio Pharmaceuticals in Q2 2020 and held it in 2 quarters.
  • ClariVest Asset Management's Inovio Pharmaceuticals position peaked at $1.86M in Q2 2020.
  • 227 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q4 2020.

Based on ClariVest Asset Management's 13F filing for Q4 2020, filed 9 Feb 2021.